| abstract |
NgR proteins and biologically active Nogo (ligand) protein fragments are disclosed. Also disclosed are compositions and methods for modifying Nogo and NgR protein expression or activity. Also disclosed are peptides that block Nogo-mediated inhibition of axonal elongation. The compositions and methods of the present invention are useful in the treatment of skull or brain trauma, spinal cord injury, stroke or demyelinating disease. |